[PHARMA] YoY Cumulative Quarter Result on 30-Sep-2023 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
29-Nov-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2023
Quarter
30-Sep-2023 [#3]
Profit Trend
QoQ- -1070.72%
YoY- -220.66%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 2,614,674 2,647,957 4,103,297 2,090,488 2,104,847 1,788,312 1,710,764 7.32%
PBT -40,724 57,549 151,987 49,299 46,609 58,280 53,198 -
Tax -3,233 -18,402 -64,947 -15,983 -17,323 -19,620 -20,299 -26.36%
NP -43,957 39,147 87,040 33,316 29,286 38,660 32,899 -
-
NP to SH -44,731 37,073 86,675 33,820 29,379 38,031 32,023 -
-
Tax Rate - 31.98% 42.73% 32.42% 37.17% 33.67% 38.16% -
Total Cost 2,658,631 2,608,810 4,016,257 2,057,172 2,075,561 1,749,652 1,677,865 7.96%
-
Net Worth -245,740 411,327 391,428 345,040 516,387 522,618 531,892 -
Dividend
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Div - 24,889 56,292 26,139 22,168 36,401 33,729 -
Div Payout % - 67.14% 64.95% 77.29% 75.46% 95.71% 105.33% -
Equity
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Net Worth -245,740 411,327 391,428 345,040 516,387 522,618 531,892 -
NOSH 1,441,229 1,309,126 1,309,126 261,705 261,229 260,505 259,821 33.03%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -1.68% 1.48% 2.12% 1.59% 1.39% 2.16% 1.92% -
ROE 0.00% 9.01% 22.14% 9.80% 5.69% 7.28% 6.02% -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
RPS 194.71 202.14 313.44 799.75 807.07 687.79 659.36 -18.38%
EPS -3.33 2.83 6.62 12.94 11.26 14.63 12.34 -
DPS 0.00 1.90 4.30 10.00 8.50 14.00 13.00 -
NAPS -0.183 0.314 0.299 1.32 1.98 2.01 2.05 -
Adjusted Per Share Value based on latest NOSH - 1,441,229
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
RPS 181.42 183.73 284.71 145.05 146.05 124.08 118.70 7.32%
EPS -3.10 2.57 6.01 2.35 2.04 2.64 2.22 -
DPS 0.00 1.73 3.91 1.81 1.54 2.53 2.34 -
NAPS -0.1705 0.2854 0.2716 0.2394 0.3583 0.3626 0.3691 -
Price Multiplier on Financial Quarter End Date
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Date 29/09/23 30/09/22 30/09/21 30/09/20 30/09/19 28/09/18 29/09/17 -
Price 0.435 0.515 0.835 4.32 2.44 2.89 4.14 -
P/RPS 0.22 0.25 0.27 0.54 0.30 0.42 0.63 -16.07%
P/EPS -13.06 18.20 12.61 33.39 21.66 19.76 33.54 -
EY -7.66 5.50 7.93 2.99 4.62 5.06 2.98 -
DY 0.00 3.69 5.15 2.31 3.48 4.84 3.14 -
P/NAPS 0.00 1.64 2.79 3.27 1.23 1.44 2.02 -
Price Multiplier on Announcement Date
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Date 29/11/23 24/11/22 19/11/21 19/11/20 20/11/19 19/11/18 15/11/17 -
Price 0.405 0.55 0.845 5.72 2.21 3.09 3.82 -
P/RPS 0.21 0.27 0.27 0.72 0.27 0.45 0.58 -15.56%
P/EPS -12.16 19.43 12.76 44.21 19.62 21.13 30.95 -
EY -8.22 5.15 7.84 2.26 5.10 4.73 3.23 -
DY 0.00 3.45 5.09 1.75 3.85 4.53 3.40 -
P/NAPS 0.00 1.75 2.83 4.33 1.12 1.54 1.86 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment